Isaac Kinde: Finding cancer via altered genes

Baltimore biotech star aims to detect cancer mutations early

Isaac Kinde headshot

DETECTION  Isaac Kinde, 31, is the chief scientific officer of PapGene, Inc. The company’s technologies can identify mutations commonly associated with cancer. 

Courtesy of I. Kinde

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content